AI assistant
Sending…
InspireMD, Inc. — Director's Dealing 2021
Apr 21, 2021
34187_dirs_2021-04-21_fc3b6431-0ace-4158-89c4-512a18a46838.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2021-04-19
Reporting Person: Slosman Marvin (Director, CEO and President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-04-19 | Option to Purchase Common Stock | $0.46 | A | 600000 | Acquired | 2031-04-19 | Common Stock (600000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1453538 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants | $ | Common Stock () | 75710 | Direct |
Footnotes
F1: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
F2: These options vest and become exercisable in three equal installments, with 1/3 vesting on each of April 19, 2022, April 19, 2023 and April 19, 2024, subject to the Reporting Person's continued service.
More from InspireMD, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 3
Board/Management Information
2026
May 22
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 20
Capital/Financing Update
2026
Apr 3
Capital/Financing Update
2026
Apr 3
Annual Report
2026
Mar 18
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 11
Major Shareholding Notification
2026
Feb 2